自适应临床试验的关键设计考量:面向临床医生的入门指南
本文综述了自适应临床试验设计中的重要考量,此类试验允许在数据收集过程中持续修改设计要素。自适应设计有望减少资源消耗、缩短试验完成时间、减少受试者分配至劣效干预,并提高结果科学或临床相关性。文章回顾了自适应试验特征与常见修改类型,并以案例形式提供实用设计指南。
要点
- 自适应试验在数据收集期间允许甚至要求对设计关键要素进行持续修改。
- 适应性决策基于预设决策规则,需在首例受试者入组前经统计模拟严格检验。
- 常见修改类型包括调整样本量、分配比例等,设计需兼顾资源与时间效率。
核心结论
- 自适应设计有望减少资源使用、缩短试验完成时间、减少受试者分配至劣效干预,并提高结果科学或临床相关性。
研究设计与样本
- 本文为综述性文章,回顾自适应临床试验的重要考量、常见研究修改类型,并以案例提供实用设计指南。
主要发现
- 自适应设计与传统试验不同,允许甚至强制在数据收集期间对试验设计关键组成部分进行持续修改。
- 自适应设计的应用已从主要评价药物扩展至更广泛领域。
- 适应性决策并非随意,而是基于首例受试者入组前经统计模拟严格检验的决策规则。
- 美国食品药品监督管理局近期发布了自适应试验设计指南,强调一般原则和不同类型,但未提供具体设计考量。
临床怎么用
- 临床研究者规划自适应试验时,应预先通过统计模拟严格检验适应性决策规则。
- 设计时应参考本文提供的实用指南与案例,明确常见研究修改类型及其适用条件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This article reviews important considerations for researchers who are designing adaptive clinical trials. These differ from conventional clinical trials because they allow and even enforce continual modifications to key components of trial design while data are being collected. This innovative approach has the potential to reduce resource use, decrease time to trial completion, limit allocation of participants to inferior interventions, and improve the likelihood that trial results will be scientifically or clinically relevant. Adaptive designs have mostly been used in trials evaluating drugs, but their use is spreading. The US Food and Drug Administration recently issued guidance on adaptive trial designs, which highlighted general principles and different types of adaptive clinical trials but did not provide concrete guidance about important considerations in designing such trials. Decisions to adapt a trial are not arbitrary; they are based on decision rules that have been rigorously examined via statistical simulations before the first trial participant is enrolled. The authors review important characteristics of adaptive trials and common types of study modifications and provide a practical guide, illustrated with a case study, to aid investigators who are planning an adaptive clinical trial
引用
- Thorlund K, Haggstrom J, Park JJ, et al. Key design considerations for adaptive clinical trials: a primer for clinicians. BMJ. 2018. PMID: 29519932. doi:10.1136/bmj.k698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。